Lumos Pharma (LUMO)
(Delayed Data from NSDQ)
$2.62 USD
+0.08 (3.15%)
Updated May 20, 2024 04:00 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Earnings News For LUMO
-
Lumos: Q1 Earnings Snapshot
-
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
-
Lumos: Q3 Earnings Snapshot
-
Lumos Pharma (LUMO) Reports Q3 Loss, Lags Revenue Estimates
-
Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
-
Lumos Pharma (LUMO) Reports Q2 Loss, Tops Revenue Estimates
-
Lumos: Q2 Earnings Snapshot
-
Lumos Pharma Reports Second Quarter 2023 Financial Results, Provides Clinical Update
-
Lumos Pharma (LUMO) Reports Q1 Loss, Tops Revenue Estimates
-
Lumos: Q1 Earnings Snapshot
-
Lumos Pharma Reports First Quarter 2023 Financial Results, Provides Clinical Updates
-
Lumos Pharma (LUMO) Reports Q4 Loss, Tops Revenue Estimates
-
Lumos Pharma (LUMO) Reports Q3 Loss, Tops Revenue Estimates
-
Lumos: Q3 Earnings Snapshot
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma (LUMO) Reports Q2 Loss, Tops Revenue Estimates
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma (LUMO) Expected to Beat Earnings Estimates: Should You Buy?
-
Will Lumos Pharma (LUMO) Report Negative Earnings Next Week? What You Should Know
-
Lumos Pharma (LUMO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release